Physician profile
Daniel E Rasmussen
NPI 1407000300
$1,389.03
in general payments reported to CMS, 2019-2025
17 companies · $507 in 2025
The $507 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $104 · 2021: $67.37 · 2022: $188 · 2023: $112 · 2024: $262 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $521.01 | 2022-2025 | Azstarys |
| Pfizer INC. | $249.64 | 2019-2025 | |
| Glaxosmithkline, LLC. | $116.18 | 2019-2024 | Bexsero, Pediarix |
| Supernus Pharmaceuticals, INC. | $99.93 | 2021-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $99.80 | 2020-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Ironshore Pharmaceuticals INC. | $66.81 | 2019-2024 | |
| Sanofi Pasteur INC. | $45.46 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $36.25 | 2023-2024 | |
| Collegium Pharmaceutical, INC. | $34.25 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $25.62 | 2022 | |
| Sobi, INC | $17.02 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.20 | 2024 | Relexxii |
| Celgene Corporation | $13.69 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.56 | 2022 | |
| Alexion Pharmaceuticals, INC. | $13.38 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.20 | 2019 | |
| Kaleo, INC. | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rasmussen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.